152 related articles for article (PubMed ID: 21613307)
21. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
Lu T; Drlica K
J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
[TBL] [Abstract][Full Text] [Related]
22. Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany.
Glocker E; Bogdan C; Kist M
J Antimicrob Chemother; 2007 May; 59(5):874-9. PubMed ID: 17350989
[TBL] [Abstract][Full Text] [Related]
23. mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis.
Pasca MR; Guglierame P; De Rossi E; Zara F; Riccardi G
Antimicrob Agents Chemother; 2005 Nov; 49(11):4775-7. PubMed ID: 16251328
[TBL] [Abstract][Full Text] [Related]
24. Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method.
Robledo J; Mejia GI; Paniagua L; Martin A; Guzmán A
Int J Tuberc Lung Dis; 2008 Dec; 12(12):1482-4. PubMed ID: 19017461
[TBL] [Abstract][Full Text] [Related]
25. [Cross-resistance between rifampicin and rifabutin among multi-drug resistant Mycobacterium tuberculosis strains].
Chikamatsu K; Mizuno K; Yamada H; Mitarai S
Kekkaku; 2009 Sep; 84(9):631-3. PubMed ID: 19860266
[TBL] [Abstract][Full Text] [Related]
26. Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis.
Foongladda S; Roengsanthia D; Arjrattanakool W; Chuchottaworn C; Chaiprasert A; Franzblau SG
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1118-22. PubMed ID: 12546122
[TBL] [Abstract][Full Text] [Related]
27. Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan.
Hillemann D; Kubica T; Agzamova R; Venera B; Rüsch-Gerdes S; Niemann S
Int J Tuberc Lung Dis; 2005 Oct; 9(10):1161-7. PubMed ID: 16229229
[TBL] [Abstract][Full Text] [Related]
28. Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates.
Soudani A; Hadjfredj S; Zribi M; Masmoudi A; Messaoud T; Tiouri H; Fendri C
J Clin Microbiol; 2007 Sep; 45(9):3095-7. PubMed ID: 17652484
[TBL] [Abstract][Full Text] [Related]
29. Clinically relevant mutations in mycobacterial LepA cause rifampicin-specific phenotypic resistance.
Wang BW; Zhu JH; Javid B
Sci Rep; 2020 May; 10(1):8402. PubMed ID: 32439911
[TBL] [Abstract][Full Text] [Related]
30. [Quantitative proteomics analysis of ClpS-mediated rifampicin resistance in Mycobacterium].
Adilijiang G; Feng S; Mi K; Deng H
Sheng Wu Gong Cheng Xue Bao; 2014 Jul; 30(7):1115-27. PubMed ID: 25345012
[TBL] [Abstract][Full Text] [Related]
31. Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis.
Piddock LJ; Williams KJ; Ricci V
J Antimicrob Chemother; 2000 Feb; 45(2):159-65. PubMed ID: 10660497
[TBL] [Abstract][Full Text] [Related]
32. High-throughput mutagenesis and screening approach for the identification of drug-resistant mutations in the rifampicin resistance-determining region of mycobacteria.
Zhao H; Li J; Feng S; Xu L; Yan B; Li C; Li M; Wang Y; Li Y; Liang L; Zhou D; Wan J; Wang W; Tian GB; Gu B; Huang X
Int J Antimicrob Agents; 2024 Jun; 63(6):107158. PubMed ID: 38537722
[TBL] [Abstract][Full Text] [Related]
33. Multidrug resistance of a porin deletion mutant of Mycobacterium smegmatis.
Stephan J; Mailaender C; Etienne G; Daffé M; Niederweis M
Antimicrob Agents Chemother; 2004 Nov; 48(11):4163-70. PubMed ID: 15504836
[TBL] [Abstract][Full Text] [Related]
34. A new dehydratase conferring innate resistance to thiacetazone and intra-amoebal survival of Mycobacterium smegmatis.
Carrère-Kremer S; Blaise M; Singh VK; Alibaud L; Tuaillon E; Halloum I; van de Weerd R; Guérardel Y; Drancourt M; Takiff H; Geurtsen J; Kremer L
Mol Microbiol; 2015 Jun; 96(5):1085-102. PubMed ID: 25754266
[TBL] [Abstract][Full Text] [Related]
35. Inactivation of the organic hydroperoxide stress resistance regulator OhrR enhances resistance to oxidative stress and isoniazid in Mycobacterium smegmatis.
Saikolappan S; Das K; Dhandayuthapani S
J Bacteriol; 2015 Jan; 197(1):51-62. PubMed ID: 25313389
[TBL] [Abstract][Full Text] [Related]
36. Selective Pressure by Rifampicin Modulates Mutation Rates and Evolutionary Trajectories of Mycobacterial Genomes.
Cebrián-Sastre E; Chiner-Oms A; Torres-Pérez R; Comas I; Oliveros JC; Blázquez J; Castañeda-García A
Microbiol Spectr; 2023 Aug; 11(4):e0101723. PubMed ID: 37436169
[TBL] [Abstract][Full Text] [Related]
37. Investigation of rifampicin resistance mechanisms in Brucella abortus using MS-driven comparative proteomics.
Sandalakis V; Psaroulaki A; De Bock PJ; Christidou A; Gevaert K; Tsiotis G; Tselentis Y
J Proteome Res; 2012 Apr; 11(4):2374-85. PubMed ID: 22360387
[TBL] [Abstract][Full Text] [Related]
38. [A hemerythrin-like protein MSMEG_3312 influences erythromycin resistance in mycobacteria].
Huang L; Hu X; Tao J; Mi K
Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1279-88. PubMed ID: 25752134
[TBL] [Abstract][Full Text] [Related]
39. Species-Specific Interactions of Arr with RplK Mediate Stringent Response in Bacteria.
Agrawal P; Varada R; Sah S; Bhattacharyya S; Varshney U
J Bacteriol; 2018 Mar; 200(6):. PubMed ID: 29311276
[TBL] [Abstract][Full Text] [Related]
40. Ethidium bromide transport across Mycobacterium smegmatis cell-wall: correlation with antibiotic resistance.
Rodrigues L; Ramos J; Couto I; Amaral L; Viveiros M
BMC Microbiol; 2011 Feb; 11():35. PubMed ID: 21332993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]